TY - JOUR
T1 - The Impact of Clinical and Pathological Features on Intraductal Papillary Mucinous Neoplasm Recurrence After Surgical Resection
T2 - Long-Term Follow-Up Analysis
AU - Pflüger, Michael J.
AU - Griffin, James F.
AU - Hackeng, Wenzel M.
AU - Kawamoto, Satomi
AU - Yu, Jun
AU - Chianchiano, Peter
AU - Shin, Eunice
AU - Lionheart, Gemma
AU - Tsai, Hua Ling
AU - Wang, Hao
AU - Rezaee, Neda
AU - Burkhart, Richard A.
AU - Cameron, John L.
AU - Thompson, Elizabeth D.
AU - Wolfgang, Christopher L.
AU - He, Jin
AU - Brosens, Lodewijk A.A.
AU - Wood, Laura D.
N1 - Funding Information:
The authors thank Dr. Ralph Hruban for helpful discussions. The authors acknowledge the following sources of support: NIH/NCI P50 CA62924; NIH/NIDDK K08 DK107781; Sol Goldman Pancreatic Cancer Research Center; Buffone Family Gastrointestinal Cancer Research Fund; Carol S. and Robert M. Long Pancreatic Cancer Research Fund; Kaya Tuncer Career Development Award in Gastrointestinal Cancer Prevention; AGA-Bernard Lee Schwartz Foundation Research Scholar Award in Pancreatic Cancer; Sidney Kimmel Foundation for Cancer Research Kimmel Scholar Award; AACR-Incyte Corporation Career Development Award for
Funding Information:
L.D.W. receives research funding from Applied Materials.
Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/6/1
Y1 - 2022/6/1
N2 - OBJECTIVE: This study aimed to identify risk factors for recurrence after pancreatic resection for intraductal papillary mucinous neoplasm (IPMN). SUMMARY BACKGROUND DATA: Long-term follow-up data on recurrence after surgical resection for IPMN are currently lacking. Previous studies have presented mixed results on the role of margin status in risk of recurrence after surgical resection. METHODS: A total of 126 patients that underwent resection for noninvasive IPMN were followed for a median of 9.5 years. Dedicated pathological and radiological reviews were performed to correlate clinical and pathological features (including detailed pathological features of the parenchymal margin) with recurrence after surgical resection. In addition, in a subset of 32 patients with positive margins, we determined the relationship between the margin and original IPMN using driver gene mutations identified by next-generation sequencing. RESULTS: Family history of pancreatic cancer and high-grade IPMN was identified as risk factors for recurrence in both uni- and multivariate analysis (adjusted hazard ratio 3.05 and 1.88, respectively). Although positive margin was not significantly associated with recurrence in our cohort, the size and grade of the dysplastic focus at the margin were significantly correlated with recurrence in margin-positive patients. Genetic analyses showed that the neoplastic epithelium at the margin was independent from the original IPMN in at least 9 of 32 cases (28%). The majority of recurrences (74%) occurred after 3 years, and a significant minority (32%) occurred after 5 years. CONCLUSION: Sustained postoperative surveillance for all patients is indicated, particularly those with risk factors such has family history and high-grade dysplasia.
AB - OBJECTIVE: This study aimed to identify risk factors for recurrence after pancreatic resection for intraductal papillary mucinous neoplasm (IPMN). SUMMARY BACKGROUND DATA: Long-term follow-up data on recurrence after surgical resection for IPMN are currently lacking. Previous studies have presented mixed results on the role of margin status in risk of recurrence after surgical resection. METHODS: A total of 126 patients that underwent resection for noninvasive IPMN were followed for a median of 9.5 years. Dedicated pathological and radiological reviews were performed to correlate clinical and pathological features (including detailed pathological features of the parenchymal margin) with recurrence after surgical resection. In addition, in a subset of 32 patients with positive margins, we determined the relationship between the margin and original IPMN using driver gene mutations identified by next-generation sequencing. RESULTS: Family history of pancreatic cancer and high-grade IPMN was identified as risk factors for recurrence in both uni- and multivariate analysis (adjusted hazard ratio 3.05 and 1.88, respectively). Although positive margin was not significantly associated with recurrence in our cohort, the size and grade of the dysplastic focus at the margin were significantly correlated with recurrence in margin-positive patients. Genetic analyses showed that the neoplastic epithelium at the margin was independent from the original IPMN in at least 9 of 32 cases (28%). The majority of recurrences (74%) occurred after 3 years, and a significant minority (32%) occurred after 5 years. CONCLUSION: Sustained postoperative surveillance for all patients is indicated, particularly those with risk factors such has family history and high-grade dysplasia.
KW - Adenocarcinoma, Mucinous/genetics
KW - Carcinoma, Pancreatic Ductal/genetics
KW - Carcinoma, Papillary/pathology
KW - Follow-Up Studies
KW - Humans
KW - Margins of Excision
KW - Neoplasm Recurrence, Local/pathology
KW - Pancreatectomy/methods
KW - Pancreatic Intraductal Neoplasms/genetics
KW - Pancreatic Neoplasms/genetics
KW - Retrospective Studies
KW - progression
KW - intraductal papillary mucinous neoplasm
KW - recurrence
KW - pancreatic cancer
KW - surveillance
UR - http://www.scopus.com/inward/record.url?scp=85121676429&partnerID=8YFLogxK
U2 - 10.1097/SLA.0000000000004427
DO - 10.1097/SLA.0000000000004427
M3 - Article
C2 - 33214420
SN - 0003-4932
VL - 275
SP - 1165
EP - 1174
JO - Annals of Surgery
JF - Annals of Surgery
IS - 6
ER -